EPISODE · Dec 11, 2019 · 27 MIN
Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma
from AUAUniversity · host American Urological Association
Co-Host: Brian M. Shuch, MD At the conclusion of these activities, participants will be able to: 1. Describe a patient-specific treatment plan that optimizes the use of targeted and immunological agents for the treatment of kidney cancer. 2. Explain best practices in RCC patient selection for various treatment options CME Available: https://auau.auanet.org/node/26099 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma
What this episode covers
Co-Host: Brian M. Shuch, MD At the conclusion of these activities, participants will be able to: 1. Describe a patient-specific treatment plan that optimizes the use of targeted and immunological agents for the treatment of kidney cancer. 2. Explain best practices in RCC patient selection for various treatment options CME Available: https://auau.auanet.org/node/26099 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma
NOW PLAYING
Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.